ASSESSING GENOTYPE-PHENOTYPE RELATIONSHIP IN CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY
Main Article Content
Abstract
Congenital adrenal hyperplasia is a disease caused by mutations in the CYP21A2 gene that partially or completely affect 21-hydroxylase enzyme function. Researchs have shown a strong correlation between genotype and phenotype of congenital adrenal hyperplasia patients and have classified CYP21A2 mutations into four groups (NULL, A, B, C) based on the effects of the mutations on 21-hydroxylase function. The study was conducted with the aim of: Evaluating the correlation between genotype and phenotype in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 183 patients were selected for the study; the patients were evaluated for clinical characteristics and genotype-phenotype correlation were assessed. The results showed that the genotype group NULL accounted for 49%, A accounted for 31%, group B 18% and group C 2%. Evaluation of the correlation between genotype and phenotype showed that the positive predictive value of the four mutation groups (NULL, A, B, C) were 99.8%; 96.5%; 90.6% and 100%. Analysis of the level of virilization showed that the NULL group had the highest severity of virilization, in which Prader IV-V accounted for 56.1%, Prader III accounted for 39%. Group A had the highest proportion of Prader III (68.2%). Group B genotypes have Prader I-II accounted for 40% and III accounted for 40%. Group C patients exhibit only grade I Prader.
Article Details
Keywords
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Genotype-Phenotype correlation, 21-Hydroxylase
References
2. White P.C. (2000). Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocr Rev, 21(3), 245–291.
3. Gonçalves J., Friães A., và Moura L. (2007). Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency. Expert Rev Mol Med, 9(11), 1–23.
4. Krone N., Braun A., Roscher A.A. và cộng sự. (2000). Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab, 85(3), 1059–1065.
5. Krone N. và Arlt W. (2009). Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab, 23(2), 181–192.
6. New M.I. (2003). Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol, 211(1–2),75–84.
7. Jääskeläinen J., Levo A., Voutilainen R. và cộng sự. (1997). Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab, 82(10), 3293–3297.
8. Rafał Podgórski, David Aebisher, Monika Stompor, Dominika Podgórska , Artur Mazur (2018). Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods. Acta Biochim Pol., 65(1),25-33